Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that the Company will report its first quarter financial results on Tuesday, May 6, 2014 after the close of the financial markets. The company will host a conference call following the announcement at 2:00 p.m. P.T./5:00 pm E.T. to discuss financial and business results. Galena Biopharma Inc. (NASDAQ:GALE) stock opened today at $2.40 and is currently trading at $2.41. The stock showed a positive weekly performance of 29.19%.
Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) noticed increases in sales and profit in the first quarter on growing demand for its flagship H.P. Acthar Gel product, the company reported after the close of the stock market. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock opened at $79.25, in current trading session and currently is at $79.64, by gaining 0.67%. The 52 week range of $29.00 – $85.69. Company’s market capitalization is 4.82 billion.
Aegis Capital affirms Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) at Buy with a price target of $28 following news that the company initiated its second phase 3 for plecanatide. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) stock is currently trading at $4.78. The EPS of the stock is -0.74. Company’s market capitalization is 447.25 million.
Gilead Sciences, Inc. (NASDAQ:GILD) very recently made an announcement that it will be releasing its results for the first quarter of this year. The company also verified that Gilead would also organize a conference call for discussing the results for the convenience of the common man and sometimes states, as well. The call will be accessible through the Internet. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened the session at $74.67, and now is at $74.90. The 52 week range of the Gilead Sciences, Inc. (NASDAQ:GILD) stock remained $46.70 – $84.88 and the day range was $74.00 – $75.15.
Leave a Reply